23andMe (NASDAQ: ME), which famously provided customers with personalized ancestry and genetic risk reports, has filed for bankruptcy in the US. The company found itself grappling with a sharp decline in demand, a debilitating 2023 data breach, and mounting financial losses that stripped its market valuation from a high of $6 billion to just $48 … Continue reading 23AndMe: Bankruptcy Filing Leaves Genetic Data on the Auction Block